BRTX (BRTX) Stock Price & Analysis
BRTX (BRTX) fell 5.57% to USD 2.8 as of September 8, 2026 at 23:34 UTC, according to Nexqual real-time market data.
BRTX last closed at USD 2.8; the session ranged USD 2.7–3.23 on volume of 55,318 shares. Market capitalization is —, with a 52-week range of USD 2.7–34.6 (NCM). Source: Nexqual, September 8, 2026 at 23:34 UTC.
Key Statistics (as of September 8, 2026 at 23:34 UTC)
| Price | USD 2.8 |
|---|---|
| Change | ▼ 5.57% (down) |
| Previous Close | USD 2.8 |
| Open | USD 2.8 |
| Day Range | USD 2.7 – 3.23 |
| 52-Week Range | USD 2.7 – 34.6 |
| Volume | 55,318 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (BRTX)
Nexqual's technical model rates BRTX "BUY" based on 5 bullish and 3 bearish signals across 93 daily candles, as of September 8, 2026 at 23:34 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 90.66 (overbought) |
| vs SMA50 | Above (USD 0.44) |
| MACD | 0.35 (positive) |
From BRTX's Latest SEC 10-K Filing (filed 2026-03-26)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CELZ | Creative Medical Technology Hol | USD 1.08 | ▲ 1.89% |
| ENSC | Ensysce Biosciences, Inc. | USD 0.47 | ▲ 7.5% |
| BCDA | BioCardia, Inc. | USD 1.11 | ▲ 1.83% |
| CMND | Clearmind Medicine Inc. | USD 1.03 | ▼ 39.41% |
| KPRX | Kiora Pharmaceuticals, Inc. | USD 2.51 | ▼ 1.57% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 23:34 UTC. This page is informational and not investment advice.